切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2010, Vol. 04 ›› Issue (03) : 288 -297. doi: 10.3877/cma.j.issn.1674-0807.2010.03.0019

临床研究

自体外周血造血干细胞移植联合大剂量化疗的高危乳腺癌患者生活质量分析
张丽1, 佟仲生1,(), 李淑芬1, 任秀宝2, 任宝柱2, 汪旭1, 曹水2, 王忱1, 何丽宏1   
  1. 1.300060 天津,医科大学附属肿瘤医院乳腺内科 国家乳腺癌防治重点实验室 天津市“肿瘤防治”重点实验室
    2.300060 天津,生物治疗科 天津“肿瘤防治”重点实验室
  • 收稿日期:2008-12-27 出版日期:2010-06-01
  • 通信作者: 佟仲生

Analysis of quality of life in high-risk breast cancer patients with autologous peripheral blood stem cell transplantation and high-dose chemotherapy

Li ZHANG1, Zhong-sheng TONG,1(), Shu-fen LI1, Xiu-bao REN1, Bao-zhu REN1, Xu WANG1, Shui CAO1, Chen WANG1, Li-hong HE1   

  1. 1.Department of Breast Oncology,Cancer Institute and Hospital,Tianjin Medical University,Tianjin 300060,China
  • Received:2008-12-27 Published:2010-06-01
  • Corresponding author: Zhong-sheng TONG
引用本文:

张丽, 佟仲生, 李淑芬, 任秀宝, 任宝柱, 汪旭, 曹水, 王忱, 何丽宏. 自体外周血造血干细胞移植联合大剂量化疗的高危乳腺癌患者生活质量分析[J/OL]. 中华乳腺病杂志(电子版), 2010, 04(03): 288-297.

Li ZHANG, Zhong-sheng TONG, Shu-fen LI, Xiu-bao REN, Bao-zhu REN, Xu WANG, Shui CAO, Chen WANG, Li-hong HE. Analysis of quality of life in high-risk breast cancer patients with autologous peripheral blood stem cell transplantation and high-dose chemotherapy[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2010, 04(03): 288-297.

目的

分析自体外周血造血干细胞移植(ASCT)联合大剂量化疗(HDCT)的高危乳腺癌患者在移植前后生活质量的变化情况,以期为医务工作者选择有针对性和有效性的干预措施改善患者的生活质量提供参考。

方法

选取2000~2003年本院经手术病理确诊并接受ASCT 联合HDCT 的61例女性高危乳腺癌患者,中位年龄46岁,作为病例组;用随机数字表法在320个普通健康人群中选取50例35~65岁健康女性作为对照组。采用欧洲癌症研究与治疗组织生活质量问卷第三版(EORTC QLQ-C30 version 3.0)作为问卷调查表。病例组选取5个时间点在患者返院复查时填写调查表,对照组经得同意后填写调查表,根据各个条目得分情况进行分析。采用重复测量法和两独立样本t检验进行统计分析。

结果

总体上患者在ASCT 结束后3个月生活质量最差,此后逐渐恢复接近健康人水平,但很多方面仍与健康人相比存在明显差别。躯体功能在ASCT 前后无显著性差别,但ASCT 后5年的患者与对照组之间差异有统计学意义(P=0.000)。患者的情绪功能在ASCT 后3个月时较ASCT前明显降低(P=0.000),虽然ASCT 后3 年较ASCT 前显著升高(P=0.000),但ASCT 后5年与健康对照组比较差异有统计学意义(P=0.011)。患者疲劳症状在ASCT 后3个月比ASCT 前显著增加(P=0.000),而随着时间推移有所缓解,ASCT后5年此症状才出现明显减轻,但较健康对照组差异有统计学意义(P=0.031)。病例组患者恶心呕吐症状在ASCT 后3个月最明显,此后逐渐缓解,ASCT 后3年明显改观,ASCT 后5年与健康对照组相比差异无统计学意义(P=0.474)。病例组患者疼痛症状在ASCT 前后一直存在,ASCT 后5年与健康对照组比较差异有统计学意义(P=0.014)。病例组患者经济困难在ASCT 前与ASCT 后3个月间差异有显著的统计学意义(P=0.000),ASCT 后5年有所缓解,但与健康对照组相比仍存在较为严重的经济问题(P=0.005)。

结论

ASCT 后患者普遍存在躯体功能受损、记忆力减退、社会家庭功能退缩、精神紧张、易疲劳、疼痛、经济困难等生活质量下降的情况,大部分可在移植后5年恢复到健康人水平,而躯体功能、疼痛症状、经济等方面仍存在严重问题。医护人员及患者家人应当给予精心护和理解照顾,帮助患者尽快改善生活质量、恢复正常生活。

Objective

To analyze the quality of life in high-risk breast cancer patients with autologous peripheral blood stem cell transplantation(ASCT)plus highdose chemotherapy (HDCT)in order to provide reference for doctors to select effective therapy and improve patients'life quality.

Methods

From 2000 to 2003,61 high risk breast cancer patients pathologically diagnosed and treated with ASCT plus HDCT in our hospital were selected as the patients group,and 50 healthy people were randomly selected from healthy population as the control group.EORTC QLQ-C30 version 3.0(the quality of life questionnaire version 3.0 by European Organization for Research and Treatment of Cancer)was used for questionary.In the patients group 5 time points before and after ASCT were chosen and the patients were asked to fill in the questionary when they came to the hospital for re-examination,and the healthy people of the control group filled in the questionary at their consent.The scores obtained by the two groups were analyzed and compared.Repeated measurement and students't test were used for statistical analysis.

Results

Generally speaking,the patients'life quality was the poorest at 3 months after ASCT.With the time passing by,the patients were getting better and better,but they still had many problems in their life,their life quality was poorer than that of the healthy controls.The physical function in the patients group was not significantly different before and after ASCT,and even 5 years after ASCT the patients'life quality was still poorer than that of the healthy controls,with statistical difference between the two groups(P=0.000).The emotional function of the patients group at 3 months after ASCT was the worst,much worse than before ASCT(P=0.000),then became better and better,though it was much better 3 years after ASCT than 3 months after ASCT(P=0.000),it was still worse 5 years after ASCT compared to the healthy controls(P=0.011).Fatigue in the patients group after ASCT increased markedly and was statistically different 3 months after ASCT compared with before ASCT(P=0.000),then abated with time,but 5 years after ASCT there was still statistical difference between the patients group and the healthy controls(P=0.031).Nausea and vomiting of the patients were most obvious at 3 months after ASCT,then relieved with time,and improved 3 years after ASCT,and 5 years after ASCT there was no statistical difference between the patients group and the healthy controls(P=0.474).Patients had pain all the time before and after ASCT,and there was a statistical difference between the patients group 5 years after ASCT and the healthy controls(P=0.014).For economy status,in the patients group there was statistically significant difference between before ASCT and 3 months after ASCT(P=0.000),the economic status became better 5 years after ASCT,but the patients still had more economic problems and difficulties,with statistical difference compared with the healthy controls(P=0.005).

Conclusion

ASCT breast cancer patients generally have problems like lesion in physical function,decrease of memoey,decrease of social and family functioning,mental tension,pain,fatigue,economic difficulties,and descent of life quality.Most patients can recover gradually to the level of healthy people 5 years after operation.But physical function,pain and economic difficulties can not be satistactorily improved.So doctors and family members should give great understanding and care to the patients,and help them to improve and recover their life as soon as possible.

表1 病例组和对照组的一般情况
图1 病例组5个时间点及对照组功能子量表及总体健康状况
图2 病例组5个时间点及对照组症状量表与各单项条目
表2 病例组在ASCT 前后5个时间点EORTC QLQ-C30测评得分情况
表3 病例组在ASCT 后5年与健康对照组EORTC QLQ-C30测评得分情况
[1]
Partridge AH,Bunnell CA,Winer EP.Quality of life issues among women undergoing high-dose chemotherapy for breast cancer.Breast Dis,2001,14:41-50.
[2]
江敏俊,徐一峰.生活质量量表(QLQ-C30)在乳腺癌患者生活质量的研究.上海精神医学,2006,18:302-305.
[3]
Aaronson NK,Ahmedzai S,Bergman B,et al.The European organization for research and treatment of cancer QLQ-C30:a quality of life instrument for use in international clinical trials in oncology.J Natl Cancer Inst,1993,85:365-376.
[4]
万崇华,陈明清,张灿珍,等.癌症患者生命质量测定量表EORTC-C30中文版评价.实用肿瘤学杂志,2005,20:353-355.
[5]
Andrykowski MA,Dishop MM,Hahn EA,et al.Long-term health-related quality of life,growth,and spiritual well-being after hematopoietic stem cell transplantation.J Clin Oncol,2005,23:599-608.
[6]
达万明,王存邦,钟建庭,等.自体骨髓移植后患者生存质量的动态调研.中华血液学杂志,1994,15:638-640.
[7]
Prieto JM,Atala J,Blanch J.Patient-rated emotional and physical functioning among hematologic cancer patients during hospitalization for stem-cell transplantation.Bone Marrow Transplant,2005,35:307-314.
[8]
Hjermstad MJ,Evenson SA,Kvaloy SO,et al.Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation:a prospective study.J Clin Oncol,1999,17:706-718.
[9]
Sasaki T,Akaho R,Sakamaki H.Mental disturbances during isolation in bone marrow transplant patients with leukemia.Bone Marrow Transplant,2000,25:315-318.
[10]
Yoo H,Lee K,Lee J,et al.Korean translation and validity of FACT-BMT version 4 and the quality of life in allogeneic bone marrow transplantation patients.Qual Life Res,2006,15:559-564.
[11]
Kopp M,Holzner B,Meraner V,et al.Quality of life in adult hematopoietic cell transplant patients at least 5 years after treatment:a comparison with healthy controls.Eur J Haematol,2005,74:304-308.
[12]
Edman L,Larsen J,Hǎgglund H,et al.A.Health-related quality of life,symptom distress and sense of coherence in adult survivors of allogenic stem-cell transplantation.Eur J Cancer Care(Engl),2001,10:124-130.
[13]
Eileen DH,Carol F,Ellen V,et al.Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant.Oncol Nursing Forum,2006,33:614-624.
[14]
Hjermstad MJ,Knobel H,Brinch L,et al.A Prospective study of health-related quality of life,fatigue,anxiety and depression 3-5 years after stem cell transplantation.Bone Marrow Transplant,2004,34:257-266.
[15]
Hayden PJ,Keogh F,Ni Conghaile M,et a1.A single-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukaemia in first chronic phase.Bone Marrow Transplant,2004,34:545-556.
[16]
Cook R.Economic and clinical impact of multiple myeloma to managed care.J Manag Care Pharm,2008,14(Suppl 7):19-25.
[17]
Rizzo JD,Wingard JR ,Tichelli A,et al.Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation:joint recommendations of the European Group for Blood and Marrow Transplantation,Center for International Blood and Marrow Transplant Research,and the American Society for Blood and Marrow Transplantation(EBMT/CIBMTR/ASBMT).Bone Marrow Transplant,2006,37:249-261.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[3] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[4] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[5] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[6] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[7] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[8] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[9] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[10] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[11] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[12] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[13] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[14] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[15] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
阅读次数
全文


摘要